コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in that is specific for ruminant leukocytes (leukotoxin).
2 sequence similarity with any other bacterial leukotoxin.
3 antiserum raised against the F. necrophorum leukotoxin.
4 mitans has the potential to secrete abundant leukotoxin.
5 method to partially purify large amounts of leukotoxin.
6 ich results in enhanced transcription of the leukotoxin.
7 n the activation and lytic activities of the leukotoxin.
8 ometry with biologically active biotinylated leukotoxin.
9 ctivation of the proleukotoxin to the mature leukotoxin.
10 ca that does not produce biologically active leukotoxin.
11 to be resistant to the lytic effects of the leukotoxin.
12 ost recently described S. aureus bicomponent leukotoxin.
13 ) toxin family related to the M. haemolytica leukotoxin.
14 ocidin (PVL), a well-characterized S. aureus leukotoxin.
15 s and abscess models as those containing the leukotoxin.
16 factors including bi-component pore-forming leukotoxins.
17 ar, S. aureus produces potent hemolysins and leukotoxins.
18 evolutionary histories and encode divergent leukotoxins (5.3% amino acid divergence), but both conta
19 a-hemolysin (HlyA) from Escherichia coli and leukotoxin A (LtxA) from Aggregatibacter actinomycetemco
20 ntibodies against Aa or its virulence factor leukotoxin A (LtxA) may serve as biomarkers that reveal
22 major virulence factor of this bacterium is leukotoxin, a secreted protein of high molecular weight
23 omycetemcomitans defective for production of leukotoxin, a toxin that is reportedly highly specific f
24 n LktAN684K substitution possesses wild-type leukotoxin activity against BL-3 cells and does not acqu
25 lting lktC strain (SH2099) secretes inactive leukotoxin and carries no known antibiotic resistance ge
29 acrophages, intracellular Ca2+ regulation by leukotoxin and endotoxin was studied by video fluorescen
31 sera raised against native affinity-purified leukotoxin and further extension of the sequence using i
33 us concentrations of immunoaffinity-purified leukotoxin and the cytotoxicity was analyzed by flow cyt
34 ights into chemokine receptor recognition by leukotoxins and suggests that the conserved sulfotyrosin
35 gnificantly affect the abundance of secreted leukotoxin, and we have developed a rapid (<2 h) method
36 tainly injure immune cells, the discovery of leukotoxin antagonism suggests that they may also play a
38 assing amino acids 1 to 291, indicating that leukotoxin binding domain lies within amino acids 1 to 2
40 in on the leukocyte surface that is either a leukotoxin binding site or is required for stabilization
45 expression, production, and availability of leukotoxins by USA300, which in turn impact the cytotoxi
47 the accepted view, A. actinomycetemcomitans leukotoxin can indeed destroy erythrocytes and that the
49 ion of bovine leukocytes with P. haemolytica leukotoxin caused marked cytoplasmic membrane blebbing (
53 orphologic changes in bovine leukocytes were leukotoxin dependent, because they were significantly di
58 rganism produces an exotoxin (referred to as leukotoxin) during logarithmic-phase growth that is a po
60 d high yields of prokaryotic (staphylococcal leukotoxin E) and eukaryotic (human annexin A2 protein t
68 e and negative cis-acting sequences regulate leukotoxin expression and that IS1301 may increase trans
69 that identification of factors that regulate leukotoxin expression may provide insight into M. haemol
74 olytica that does not produce any detectable leukotoxin failed to exhibit the morphologic changes cha
76 /B (LukAB), the most divergent member of the leukotoxin family, exists as a heterodimer in solution r
78 ed polypeptides recognized affinity-purified leukotoxin from F. necrophorum culture supernatant in a
81 30-bp deletion in the promoter region of the leukotoxin gene operon which results in enhanced transcr
83 s the uhpT gene and harmful superantigen and leukotoxin genes, allowing for constitutive HptARS activ
85 egion, indicative of a high level expression leukotoxin genotype, and conversion from a healthy perio
86 including Panton-Valentine leukocidin (PVL), leukotoxin GH (LukGH; also known as LukAB), leukotoxin D
87 tly identified a novel S. aureus leukotoxin (leukotoxin GH [LukGH]) using proteomics, but its role in
89 espite extensive sequence conservation, each leukotoxin has unique properties, including disparate ce
91 roach in order to characterize the effect of leukotoxins HlgA and HlgB on ACKR1 structure and functio
92 ) demonstrate that two Staphylococcus aureus leukotoxins, HlgAB and LukED, target the Duffy antigen r
93 results suggest that increased expression of leukotoxin in strain IS1 does not arise from an outwardl
96 ukAB also differs from the other bicomponent leukotoxins in that the S subunit (LukA) contains 33- an
97 of antibodies against Mannheimia haemolytica leukotoxin, in comparison to domestic sheep (DS, Ovis ar
98 staphylococcal superantigens, proteases, and leukotoxins, in addition to bacteriocins, was transferra
104 se pneumonia and that the expression of this leukotoxin induces global changes in transcriptional lev
105 variant of CU1000N), secrete an abundance of leukotoxin into the culture supernatants during early st
109 ovirus expression system we demonstrate that leukotoxin is only cytotoxic in the presence of epoxide
111 We recently identified a novel S. aureus leukotoxin (leukotoxin GH [LukGH]) using proteomics, but
113 have shown that the Pasteurella haemolytica leukotoxin (LKT) and other RTX toxins bind beta(2)-integ
115 ons of the RTX toxin Pasteurella haemolytica leukotoxin (LKT) contained LKT and LPS as the most promi
120 One example of such a toxin is the potent leukotoxin (LKT) produced by the bovine respiratory path
122 ovine neutrophils to Pasteurella haemolytica leukotoxin (LKT) stimulates the production of leukotrien
125 ipping fever pneumonia in cattle, produces a leukotoxin (LKT) which lyses ruminant leukocytes with hi
126 ys that amplified polymorphic regions in the leukotoxin (lkt), cytolethal distending toxin (cdt), maj
127 Its most important virulence factor is a leukotoxin (LKT), which is a member of the RTX family of
130 toxin proteins, the Pasteurella haemolytica leukotoxin (LktA) and the enterohemorrhagic E. coli toxi
131 the site involved in Mannheimia haemolytica leukotoxin (LktA) binding and biological activity within
141 of virulence factors, including an exotoxic leukotoxin (LtxA) that is a member of the repeats-in-tox
142 nobacillus) actinomycetemcomitans produces a leukotoxin (LtxA) that is a member of the RTX (repeats i
143 emcomitans produces a repeats-in-toxin (RTX) leukotoxin (LtxA) that selectively kills human immune ce
144 omitans, a periodontal pathogen, synthesizes leukotoxin (LtxA), a protein that helps the bacterium ev
145 inomycetemcomitans secretes a protein toxin, leukotoxin (LtxA), which helps the bacterium evade the h
151 n-inhibition paradox is explained in part by leukotoxin-mediated apoptosis (i.e., activation-induced
152 ocked by the addition of a neutralizing anti-leukotoxin monoclonal antibody and was not detected when
155 of other bacterial species are secreted, the leukotoxin of A. actinomycetemcomitans is thought to rem
158 e a specific binding site for P. haemolytica leukotoxin on bovine but not on porcine or human leukocy
159 aic structure and molecular evolution of the leukotoxin operon (lktCABD) was investigated by nucleoti
160 The recombinational exchanges within the leukotoxin operon have had greatest effect on LktA and p
161 played a major role in the evolution of the leukotoxin operon in ovine strains of M. haemolytica.
165 shed (based on the promoter structure of the leukotoxin operon) into JP2 and non-JP2 genotypes, with
167 nals to mediate the secretion of hemolysins, leukotoxins, or proteases from other bacterial species.
169 l whether the presentation of M. haemolytica leukotoxin peptides to T(h) cells by Ovca-DRB alleles is
177 ::cat operon fusion allowed us to quantitate leukotoxin promoter activity in P. haemolytica and to de
179 analyses of ltxA RNA expression from defined leukotoxin promoter mutations in the chromosome identify
180 who had variants containing the full length leukotoxin promoter region (odds ratio = 22.5; 95% C.I.,
181 , and compared with the previously sequences leukotoxin promoter region of the high-producer strain J
182 ction of variants that had a deletion in the leukotoxin promoter region, indicative of a high level e
184 To perform cis/trans analyses, these three leukotoxin promoter regions were cloned into a plasmid u
185 host factor (IHF) binds to and represses the leukotoxin promoter, but neither CRP nor IHF is responsi
187 ovine alveolar macrophages with endotoxin or leukotoxin results in the induction of cytokine gene exp
188 itans, and strains expressing high levels of leukotoxin RNA are most often found at sites of periodon
190 sequences in setting the disparate levels of leukotoxin RNA found, we have undertaken classical cis/t
191 he sequences responsible for down-regulating leukotoxin RNA levels in Y4 relative to JP2 are found wi
192 t Y4, despite the large insertion, initiates leukotoxin RNA synthesis at the same promoter as JP2 doe
193 etemcomitans; an mlc deletion mutant reduces leukotoxin RNA synthesis, and recombinant Mlc protein bi
196 e identified bovine CD18 as the receptor for leukotoxin secreted by Mannheimia (Pasteurella) haemolyt
198 appropriate to consider a possible role for leukotoxin secretion in the pathogenesis of A. actinomyc
202 lated RTX toxin, the Pasteurella haemolytica leukotoxin structural protein (LktA), can be activated i
203 protease K eliminated subsequent binding of leukotoxin, suggesting that there is a protein on the le
206 comitans strains produce 10 to 20 times more leukotoxin than other minimally leukotoxic strains.
207 nfections, such as endocarditis, expresses a leukotoxin that acts on polymorphonuclear leukocytes and
208 inobacillus actinomycetemcomitans produces a leukotoxin that is considered a primary virulence factor
210 ative virulence factors including (a) an RTX leukotoxin that targets only neutrophils and monocytes a
211 S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also
212 p to five different bicomponent pore-forming leukotoxins that lyse immune cells by forming pores in t
214 his is the first report of Ca2+ signaling by leukotoxin through a G-protein-coupled mechanism involvi
216 in vitro, the relative contribution of this leukotoxin to invasive CA-MRSA infections such as pneumo
218 We did not detect binding of biotinylated leukotoxin to porcine or human leukocytes, which have be
219 aphylococcus aureus bicomponent pore-forming leukotoxins to promote bacterial growth and immune evasi
220 t factors responsible for the selectivity of leukotoxins towards different immune cells remain unknow
221 aken studies to identify other regulators of leukotoxin transcription and to demonstrate how these pr
222 ella haemolytica cosmid clone that activates leukotoxin transcription in Escherichia coli has been is
223 nstrate that, like that of other RTX toxins, leukotoxin transcription is environmentally regulated.
229 ometric analysis showed that the recombinant leukotoxin was active against bovine polymorphonuclear l
230 e as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to i
231 hich affect a variety of cell types, and the leukotoxins, which are cell-type- and species-specific.
232 virulence factors, including the bicomponent leukotoxins, which are critical for the cytotoxicity of
233 recent advances in our understanding of how leukotoxins work in receptor-mediated or receptor-indepe
234 more, in studies on A. actinomycetemcomitans leukotoxin workers should now consider this toxin's abil